Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-25-057310)

Filing Details

Accession Number:: 0001104659-25-057310
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-06-06 16:05:31
Reporting Period:: 2025-06-05

Filing Date:: 2025-06-06
Accepted Time:: 2025-06-06 16:05:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1425205	Iovance Biotherapeutics Inc.	IOVA	Biological Products, (No Disgnostic Substances) (2836)	753254381

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2055001	Gordon Daniel Kirby	C/O Iovance Biotherapeutics, Inc. 825 Industrial Road, Suite 100 San Carlos CA 94070	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-06-05	30,000	$1.84	30,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Shares were acquired in the open market during a permitted trading window in accordance with the Issuer's Insider Trading Policy. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024.